Lantheus Holdings, Inc
Veridion Score
Composite trend over time
Why is LNTH moving today?
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for LNTH.
LNTH insider activity
Lantheus Holdings, Inc
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for LNTH.
LNTH contract awards, year to date.
Public federal awards linked to this ticker.
LNTH lobbying filings, year to date.
Registered lobbying filings matched to Lantheus Holdings, Inc.